ZA969211B - Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicament comprising them - Google Patents

Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicament comprising them

Info

Publication number
ZA969211B
ZA969211B ZA969211A ZA969211A ZA969211B ZA 969211 B ZA969211 B ZA 969211B ZA 969211 A ZA969211 A ZA 969211A ZA 969211 A ZA969211 A ZA 969211A ZA 969211 B ZA969211 B ZA 969211B
Authority
ZA
South Africa
Prior art keywords
medicament
sulfonimidamides
diagnostic
substituted
processes
Prior art date
Application number
ZA969211A
Other languages
English (en)
Inventor
Heinz-Werner Kleemann
Joachim Brendel
Jan-Robert Schwark
Andreas Weichert
Hans Jochen Lang
Udo Albus
Wolfgang Scholz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA969211B publication Critical patent/ZA969211B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/10—Compounds containing sulfur atoms doubly-bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA969211A 1995-11-03 1996-11-01 Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicament comprising them ZA969211B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19540995A DE19540995A1 (de) 1995-11-03 1995-11-03 Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
ZA969211B true ZA969211B (en) 1997-05-03

Family

ID=7776535

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969211A ZA969211B (en) 1995-11-03 1996-11-01 Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicament comprising them

Country Status (30)

Country Link
US (1) US5708034A (cs)
EP (1) EP0771788B1 (cs)
JP (1) JP3924028B2 (cs)
KR (1) KR970025611A (cs)
CN (1) CN1069312C (cs)
AR (1) AR004253A1 (cs)
AT (1) ATE188688T1 (cs)
AU (1) AU707256B2 (cs)
BR (1) BR9605417A (cs)
CA (1) CA2189221C (cs)
CZ (1) CZ290811B6 (cs)
DE (2) DE19540995A1 (cs)
DK (1) DK0771788T3 (cs)
ES (1) ES2143122T3 (cs)
GR (1) GR3032689T3 (cs)
HR (1) HRP960496B1 (cs)
HU (1) HUP9603023A3 (cs)
IL (1) IL119552A (cs)
MX (1) MX9605317A (cs)
MY (1) MY132862A (cs)
NO (1) NO306550B1 (cs)
NZ (1) NZ299682A (cs)
PL (1) PL184570B1 (cs)
PT (1) PT771788E (cs)
RU (1) RU2180658C2 (cs)
SI (1) SI0771788T1 (cs)
SK (1) SK281766B6 (cs)
TR (1) TR199600873A2 (cs)
TW (1) TW352382B (cs)
ZA (1) ZA969211B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE19832429A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832428A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP3312160B1 (en) 2011-12-21 2020-03-18 Novira Therapeutics Inc. Hepatitis b antiviral agents
AR092270A1 (es) 2012-08-28 2015-04-08 Janssen R&D Ireland Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
JP6466348B2 (ja) 2013-02-28 2019-02-06 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用
EA027068B1 (ru) 2013-04-03 2017-06-30 Янссен Сайенсиз Айрлэнд Юси Производные n-фенилкарбоксамида и их применение в качестве лекарственных препаратов для лечения гепатита b
JO3603B1 (ar) 2013-05-17 2020-07-05 Janssen Sciences Ireland Uc مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
MX366787B (es) 2013-05-17 2019-07-23 Janssen Sciences Ireland Uc Derivados de sulfamoiltiofenamida y su uso como medicamentos para tratar la hepatitis b.
EA035926B1 (ru) 2013-07-25 2020-09-01 Янссен Сайенсиз Айрлэнд Юси Производные замещенного глиоксамидом пирроламида и их применение в качестве лекарственных средств для лечения гепатита b
NZ717629A (en) 2013-10-23 2021-12-24 Janssen Sciences Ireland Uc Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
US9169212B2 (en) 2014-01-16 2015-10-27 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis B infections
US10392349B2 (en) 2014-01-16 2019-08-27 Novira Therapeutics, Inc. Azepane derivatives and methods of treating hepatitis B infections
KR20160128305A (ko) 2014-02-05 2016-11-07 노비라 테라퓨틱스, 인코포레이티드 Hbv 감염의 치료를 위한 병용 요법
JP6495929B2 (ja) 2014-02-06 2019-04-03 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー スルファモイルピロールアミド誘導体およびｂ型肝炎の治療のための医薬としてのその使用
AU2016232801A1 (en) 2015-03-19 2017-10-12 Novira Therapeutics, Inc. Azocane and azonane derivatives and methods of treating hepatitis B infections
US10875876B2 (en) 2015-07-02 2020-12-29 Janssen Sciences Ireland Uc Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
TW201718496A (zh) 2015-09-29 2017-06-01 諾維拉治療公司 B型肝炎抗病毒劑之晶型
EP3848026A1 (en) 2016-04-15 2021-07-14 Novira Therapeutics Inc. Combinations and methods comprising a capsid assembly inhibitor
EP3618790A1 (en) * 2017-01-31 2020-03-11 The Procter and Gamble Company Shaped nonwoven fabrics and articles including the same
US11214893B2 (en) 2017-06-30 2022-01-04 The Procter & Gamble Company Shaped nonwoven
WO2019005910A1 (en) 2017-06-30 2019-01-03 The Procter & Gamble Company METHOD FOR MANUFACTURING NON-WOVEN FABRIC
MA52019A (fr) 2018-03-14 2021-01-20 Janssen Sciences Ireland Unlimited Co Schéma posologique de modulateur d'assemblage de capside
CN112513048A (zh) 2018-07-20 2021-03-16 豪夫迈·罗氏有限公司 作为白细胞介素-1活性抑制剂的磺酰亚胺酰胺类化合物
WO2020169784A1 (en) 2019-02-22 2020-08-27 Janssen Sciences Ireland Unlimited Company Amide derivatives useful in the treatment of hbv infection or hbv-induced diseases
CN113473955B (zh) 2019-03-18 2023-03-28 宝洁公司 表现出高视觉分辨率的成型非织造布
WO2020225230A1 (en) 2019-05-06 2020-11-12 Janssen Sciences Ireland Unlimited Company Amide derivatives useful in the treatment of hbv infection or hbv-induced diseases
CN116492469A (zh) * 2023-05-22 2023-07-28 遵义医科大学附属医院 一种通道阻滞剂在制备治疗和/或预防肝纤维疾病药物中的应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
CA1338894C (en) * 1988-01-15 1997-02-04 John Francis De Bernardis Aminomethyl-chroman and thiochroman compounds as ó-2-adrenergic antagonists
US5140039A (en) * 1988-01-15 1992-08-18 Abbott Laboratories Aminomethyl-thiochroman compounds
US5185364A (en) * 1988-01-15 1993-02-09 Abbott Laboratories Aminomethyl-chroman and -thiochroman compounds
DE4010325A1 (de) * 1989-04-03 1990-10-04 Ciba Geigy Ag Neue carbaminsaeureester
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
US5140026A (en) * 1991-05-09 1992-08-18 A. H. Robins Company, Incorporated N-aminoalkyl-S-aryl-S-alkyl (or substituted alkyl) sulfoximines as antiarrhythmic agents
ATE139526T1 (de) * 1992-02-15 1996-07-15 Hoechst Ag 3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen
ES2108144T3 (es) * 1992-02-15 1997-12-16 Hoechst Ag Benzoilguanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
ES2092729T3 (es) * 1992-07-01 1996-12-01 Hoechst Ag Benzoilguanidinas 3,4,5-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
EP0580550B1 (en) * 1992-07-21 1997-10-22 Novartis AG Oxamic acid derivatives as hypocholesteremic agents
EP0589336B1 (de) * 1992-09-22 1997-01-08 Hoechst Aktiengesellschaft Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
ES2152938T3 (es) * 1992-09-28 2001-02-16 Hoechst Ag 1(2h)-isoquinolinas sustituidas antiarritmicas y cardioprotectoras, procedimiento para su produccion, medicamento que las contiene y su uso para la produccion de un medicamento para combatir fallos cardiacos.
ES2129485T3 (es) * 1992-12-02 1999-06-16 Hoechst Ag Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
TW250479B (cs) * 1992-12-15 1995-07-01 Hoechst Ag
TW250477B (cs) * 1992-12-15 1995-07-01 Hoechst Ag
EP0603650B1 (de) * 1992-12-16 1997-04-02 Hoechst Aktiengesellschaft 3,5-Substituierte Aminobenzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
DE59403818D1 (de) * 1993-02-20 1997-10-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
ES2098069T3 (es) * 1993-02-23 1997-04-16 Hoechst Ag Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
DE4327244A1 (de) * 1993-08-13 1995-02-16 Hoechst Ag Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4344550A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4415873A1 (de) * 1994-05-05 1995-11-09 Hoechst Ag Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4417004A1 (de) * 1994-05-13 1995-11-16 Hoechst Ag Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
IL114670A0 (en) * 1994-08-05 1995-11-27 Fujisawa Pharmaceutical Co Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
DE4432101A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432105A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Fluoro-alkyl/alkenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4432106A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung
DE4441880A1 (de) * 1994-11-24 1996-05-30 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DK0723956T3 (da) * 1995-01-30 2000-04-17 Hoechst Ag Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos

Also Published As

Publication number Publication date
IL119552A (en) 2000-09-28
DK0771788T3 (da) 2000-06-13
BR9605417A (pt) 1998-08-04
PT771788E (pt) 2000-05-31
EP0771788B1 (de) 2000-01-12
NZ299682A (en) 1997-07-27
CA2189221C (en) 2006-10-03
RU2180658C2 (ru) 2002-03-20
CZ318496A3 (en) 1997-05-14
HRP960496B1 (en) 2000-12-31
MY132862A (en) 2007-10-31
CN1069312C (zh) 2001-08-08
NO964639D0 (no) 1996-11-01
CN1155538A (zh) 1997-07-30
SK141896A3 (en) 1997-06-04
ATE188688T1 (de) 2000-01-15
JPH09169723A (ja) 1997-06-30
CA2189221A1 (en) 1997-05-04
KR970025611A (ko) 1997-06-24
JP3924028B2 (ja) 2007-06-06
NO306550B1 (no) 1999-11-22
CZ290811B6 (cs) 2002-10-16
HU9603023D0 (en) 1996-12-30
TW352382B (en) 1999-02-11
PL316440A1 (en) 1997-05-12
HUP9603023A2 (hu) 1998-01-28
IL119552A0 (en) 1997-02-18
DE19540995A1 (de) 1997-05-07
TR199600873A2 (tr) 1997-05-21
EP0771788A3 (de) 1997-09-03
DE59604165D1 (de) 2000-02-17
HUP9603023A3 (en) 1998-12-28
HRP960496A2 (en) 1998-02-28
EP0771788A2 (de) 1997-05-07
GR3032689T3 (en) 2000-06-30
NO964639L (no) 1997-05-05
ES2143122T3 (es) 2000-05-01
SI0771788T1 (en) 2000-04-30
AU7060896A (en) 1997-05-08
US5708034A (en) 1998-01-13
AR004253A1 (es) 1998-11-04
MX9605317A (es) 1997-05-31
PL184570B1 (pl) 2002-11-29
SK281766B6 (sk) 2001-07-10
AU707256B2 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
ZA969211B (en) Substituted sulfonimidamides processes for their preparation their use as a medicament or diagnostic and medicament comprising them
HRP970450B1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or diagnostic agents and drugs containing them
IL118327A0 (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides process for their preparation their use as a medicament or diagnostic and medicament containing them
IL118278A0 (en) Substituted benzyloxycarbonyl-guanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
IL120924A0 (en) Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
IL116940A0 (en) Basically-substituted benzoylguanidines a process for preparing them their use as a medicament or diagnostic agent and a medicament containing them
ZA968091B (en) Substituted benzolyguanidines a process for their preparation their use as a medicament or diagnostic agent and medicament comprising them
ZA961231B (en) Substituted benzenesulfonyllureas and -thioureas process for their preparation their use as a medicament or diagnostic and medicament containing them
IL118925A0 (en) Substituted cinnamic acid guanidides a process for their preparation their use as medicaments or diagnostic agents and medicaments comprising them
IL114377A0 (en) Ortho-amino- substituted benzoylguanidines a process for their preparation their use as a medicament or diagnostic agent and also a medicament containing them
IL118887A0 (en) 4-fluoroalkyl-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
ZA959972B (en) Substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
IL120925A0 (en) Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
ZA969521B (en) Sulfonylamino-substituted benzoylguanidines a process for their preparation their use as medicament or diagnostic aid and medicament containing them
IL120214A0 (en) Substituted thiophenylalkenylcarboxylic acid guanidides process for their preparation their use as a medicament or diagnostic and medicament containing them
ZA96720B (en) Substituted thiophenylsulfonylureas and -thioureas processes for their preparation their use as a medicament or diagnostic and medicament containing them
ZA981063B (en) Sulfonamide-substituted compounds process for their preparation their use as a medicament or diagnostic and a medicament comprising them
IL120908A0 (en) Bis-ortho-substituted benzoylguanidines processes for their preparation their use as a medicament or diagnostic and medicaments comprising them
IL120093A0 (en) Substituted diaryldicarboxylic acid diguanidides processes for their preparation their use as a medicament or diagnostic and medicament containing them
IL123874A0 (en) Ortho-substituted benzyloguanidines process for their preparation their use as a medicament or diagnostic and medicaments comprising them
ZA96644B (en) Basically-substituted benzolyguanidines a process for preparing them their use as a medicament or diagnostic agent and medicament containing them
IL120259A0 (en) Ortho-substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them
ZA986967B (en) Sulfonamide-substituted compounds processes for their preparation their use as a medicament or diagnostic and medicament comprising them